Listing Websites about Alexion Pharmaceuticals
ALXN Stock Forecast, Price & News (Alexion Pharmaceuticals)
(6 days ago) Alexion Pharmaceuticals, Inc. has collaboration and license agreement with Halozyme Therapeutics, Inc.; and agreements with Dicerna Pharmaceuticals, Inc., Zealand Pharma A/S, Caelum Biosciences, Inc., Stealth BioTherapeutics Corp., and Affibody AB. The company was founded in 1992 and is headquartered in Boston, Massachusetts.
Acquisition of Alexion completed
(8 days ago) AstraZeneca today completed the acquisition of Alexion Pharmaceuticals, Inc. (Alexion). The closing of the acquisition marks the Company’s entry into medicines for rare diseases and the beginning of a new chapter for AstraZeneca. AstraZeneca now has an enhanced scientific presence in immunology and, through Alexion’s innovative complement
Alexion Pharmaceuticals, Inc. Company Profile Boston, MA
(1 days ago) Company Description: Alexion Pharmaceuticals develops drugs that inhibit immune system functions that cause rare hematology, nephrology, neurology, metabolic disorders and cardiology. Its primary product, monoclonal antibody Soliris, treats two rare genetic blood disorders: paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
AstraZeneca to acquire Alexion, accelerating the Company's
(6 days ago) AstraZeneca and Alexion Pharmaceuticals, Inc. (Alexion) have entered into a definitive agreement for AstraZeneca to acquire Alexion. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS representing one-half of one (1/2) ordinary share of AstraZeneca, as evidenced by American Depositary Receipts (ADRs)) for each Alexion …
Working at Alexion Pharmaceuticals,Inc. in New Haven, CT
(Just Now) Alexion's vision and mission is one unparalleled with any other bio pharma company. The staff here is passionate and dedicated at 150% to the work and research performed here. As a member of the staff here it fills me with pride to know that in one way or another we all play a huge role in the success of the company and the impact it has for
Alexion (ALXN) to Be Acquired by AstraZeneca for $39
(3 days ago) Alexion Pharmaceuticals, Inc.ALXN entered into a definitive agreement with U.K.-based pharmaceutical company, AstraZeneca plc AZN, whereby the latter will acquire the former.. Per the terms
With the Alexion Acquisition Set to Close This Quarter, Is
(3 days ago) This week, pharma and biotech giant AstraZeneca cleared its final hurdle in the proposed acquisition of orphan drug pharma company Alexion Pharmaceuticals (NASDAQ:ALXN) when it announced that the
Alexion Pharmaceuticals Company Profile - Office Locations
(Just Now) Alexion Pharmaceuticals has 3,082 employees across 21 locations and $6.07 B in annual revenue in FY 2020. See insights on Alexion Pharmaceuticals including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
Alexion Pharmaceuticals Inc/MA - Company Profile and News
(9 days ago) Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases.
Alexion gMG Events
(9 days ago) Connecting patients, caregivers, and doctors in the gMG community. Ask questions and gather information about generalized myasthenia gravis (gMG) at a free webinar or in-person event. These events are open to patients and their caregivers in the United States. You’re all set, Friend! Thanks for registering for “ .”.
Alexion to Acquire Portola Alexion Pharmaceuticals, Inc.
(4 days ago) Alexion will host a conference call and webcast today, May 5, 2020 at 8:00 a.m. ET to discuss the acquisition. To participate in this call, dial (866) 762-3111 ( USA) or (210) 874-7712 (International), passcode 5689520, shortly before 8:00 a.m. ET. A replay of the call will be available for a limited period of time following the call.
Alexion Pharmaceuticals - Crunchbase Company Profile & Funding
(3 days ago) Alexion Pharmaceuticals is a biopharmaceutical company, which is engaged in the discovery, development, and commercialization of biologic therapeutic products aimed at treating patients with severe and life-threatening disease states, including hematologic, kidney and neurologic diseases, transplant rejection, cancer, and autoimmune disorders.
Working at Alexion Pharmaceuticals,Inc.: 117 Reviews
(3 days ago) Very smart people work at Alexion Pharmaceuticals. Most are very polite and professional. It was the facilities management I would recommend they improve, as a temp I was often told to do things outside of my job description (which I am okay with) but in a frequently condescending manner, I was called dumb by my own manager for one of his mistakes and was constantly overhearing much about
Andexxa reverses anticoagulant-based bleeding events.
(Just Now) Andexxa (prescribing information). Boston, MA: Alexion Pharmaceuticals, Inc.; 2021. 2. Tomaselli GF, Mahaffey KW, Cuker A, et al. 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Task Force on expert consensus decision pathways.
US Index - Alexion Clinical Trials
(4 days ago) Alexion is committed to researching rare diseases and investigating potential new treatments that could transform patients' lives. Most patients with severe and life-threatening rare diseases live with no effective treatment options and little hope of finding one. Alexion's clinical trials investigate therapies that may offer hope to people who
Working at Alexion Pharmaceuticals,Inc.: Employee Reviews
(2 days ago) Alexion Pharmaceuticals Senior Director of Finance (Former Employee) - Dublin, Ireland - 17 July 2015 Alexion is a fast-paced, forward-thinking business environment where any individual can be the source of the next strategic initiative.
Alexion Pharmaceuticals CEO And Leadership - Zippia
(Just Now) Management Team: The most common ethnicity among Alexion Pharmaceuticals executive officers is White. 61% of the management team is White. 12% of Alexion Pharmaceuticals's management is Black or African American. 11% of the management team is Asian. White is the most common ethnicity company-wide. 60% of employees are White.
Working at Alexion Pharmaceuticals Glassdoor
(9 days ago) Glassdoor gives you an inside look at what it's like to work at Alexion Pharmaceuticals, including salaries, reviews, office photos, and more. This is the Alexion Pharmaceuticals company profile. All content is posted anonymously by employees working at Alexion Pharmaceuticals.
Alexion Careers Job Search Results
(5 days ago) AstraZeneca completed its acquisition of Alexion, marking the creation of Alexion, AstraZeneca Rare Disease. If you’re interested in career opportunities with AstraZeneca, click here.. If you are a current Alexion employee, please apply via Alexion’s internal Life & Career portal.Note that you will need to be connected to the VPN if you are applying away from the office.
Alexion Pharmaceuticals: Revising My Valuation (NASDAQ
(3 days ago) Alexion Pharmaceuticals now expects fiscal 2020 revenues to fall in the range of $5.50 billion - $5.56 billion, lower than the consensus of $5.6 billion. The company has also guided for fiscal
SEC.gov SEC Charges Alexion Pharmaceuticals With FCPA
(7 days ago) The Securities and Exchange Commission today announced that Boston-based pharmaceutical company Alexion Pharmaceuticals Inc. has agreed to pay more than $21 million to resolve charges that it violated the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA).
ALEXION PHARMACEUTICALS, INC. : Shareholders Board Members
(Just Now) Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Companyâ€™s marketed products include SOLIRIS (eculizumab), Strensiq (asfotase alfa), Kanuma (sebelipase alfa), ULTOMIRIS, Andexxa and Ondexxya.
Alexion Pharmaceuticals, Inc. Email Format & Employee
(Just Now) Get details for Alexion Pharmaceuticals, Inc.’s 4 employees, email format for alexion.com and phone numbers. At Alexion, our mission is to transform the lives of people living with rare and devastating diseases through the development and delivery of innovative medicines, as well as through supportive technologies and healthcare services. \n\nBy continuing to deepen our understanding of rare
Alexion Pharmaceuticals, Inc. (ALXN) Stock Price Today
(6 days ago) A high-level overview of Alexion Pharmaceuticals, Inc. (ALXN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
ALEXION PHARMACEUTICALS, INC. : ALXN Stock Price
(2 days ago) Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic products. The Companyâ€™s marketed products include SOLIRIS (eculizumab), Strensiq (asfotase alfa), Kanuma (sebelipase alfa), ULTOMIRIS, Andexxa and Ondexxya. The Companyâ€™s clinical development
Alexion Pharmaceuticals and LenelS2 NetBox Global S2
(Just Now) Alexion could now have “a distributed, centralized network, allowing flexibility, scalability and ease of use with fully integrated access and video,” said Bob. In a lighter moment he exclaimed, “Seeing the status of Buenos Aires while in Cheshire, CT—just amazing!” LenelS2 and Alexion …
Patient Site Soliris® (eculizumab)
(3 days ago) By checking this box and submitting this form, I give Alexion permission to contact me for commercial purposes or otherwise provide me with information about Alexion’s products, services, programs, market research, or other topics of interest that Alexion thinks may interest me.
Alexion Pharmaceuticals - Home Facebook
(1 days ago) Alexion Pharmaceuticals. 11 hrs ·. People living with rare diseases and devastating conditions endure many obstacles throughout their lives. To better understand those realities and innovate for solutions, we introduced LEAP (Learn, Evolve, Activate, and deliver for Patients). Learn more about how LEAP drives us: https://bddy.me/37Nrpi4.
Environment Alexion 2020 CSR Report
(1 days ago) All employees and contractors are covered by this policy. Our environmental management system (EMS) follows widely accepted global standards, including ISO 14001, and is backed by an extensive suite of in-house EHS standards. In 2020, an independent consultant completed a comprehensive EHS audit of our manufacturing sites and R&D facilities
Alexion - Overview, News & Competitors ZoomInfo.com
(2 days ago) Alexion has acquired the companies: Caelum Biosciences Inc, Trimeris , Inc., IntraBiotics Pharmaceuticals , Inc. What is Alexion's tech stack? The technologies that are used by Alexion are: IBM SPSS, Adobe Illustrator, BlackBerry Enterprise Server, MATLAB
FAQ about Alexion Pharmaceuticals
What kind of diseases does Alexion Pharmaceuticals treat?
Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). The company is also involved in immune system research related to autoimmune diseases.
Where are the headquarters of Alexion Pharmaceuticals located?
Alexion Pharmaceuticals. The company is also involved in immune system research related to autoimmune diseases. It employs around 2,400 people worldwide. In February 2016, the company held the dedication ceremony for its new headquarters in New Haven, Connecticut, not far from the company's starting point in the same city.
Why did AstraZeneca want to buy Alexion Pharmaceuticals?
With AstraZeneca’s Revenues being increasingly dependent on cancer drugs over recent years, the move would help the company gain a foothold in the market for drugs for rare diseases. Rare diseases are a promising area for big pharma companies for a couple of reasons.
What makes Alexion the best company to work for?
We are innovators, leaders, and collaborators. And at the heart of everything we do is an intense desire to pursue the toughest challenges and truly change the world for people living with rare and devastating diseases. We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it.